ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN

Clinical trial NCT04639024 · TERMINATED

Trial details

NCT number: NCT04639024
Sponsor: Gwynn Long, M.D.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Myeloproliferative Neoplasm (MDS/MPN)

Start date: 2021-12-07
Primary completion: 2022-11-03
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.